The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database
Open accessAbstract
Background: Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal malignancies that occur throughout the lifespan. The impact of age on disease features and outcome is unclear. Methods: We analyzed the clinical features and outcome of all STS cases registered between 1973 and 2006 in the SEER database. Results: There were 48,012 cases that met the selection criteria. Individuals less than 20 years of age represented 5.6%, with rhabdomyosarcoma being the most common subtype. In adults, the most common types were Kaposi sarcoma, fibrohistiocytic tumors, and leiomyosarcoma. Rhabdomyosarcoma was the only entity with a median age <20 years. Male predominance (male/female of 1.5:1) was noticed for almost all types of STS, except for alveolar soft part sarcoma and leiomyosarcoma. Tumor stage was similar across different age groups. Younger patients (<50 years) had significantly better survival than older patients (88.8 ± 0.2% vs. 40 ± 0.3%, P < 0.001), but for most histologies the survival decline with advancing age was gradual and did not occur abruptly at the onset of adulthood. The decline in survival with advancing age was particularly significant for rhabdomyosarcoma. Conclusion: With few exceptions, the clinical features of STS are similar in children and adults. However, individuals over 50 years of age have an inferior survival. Pediatr Blood Cancer 2011; 57: 943–949. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enzinger and Weiss's Soft Tissue Tumors
Weiss, S. W., & Goldblum, J. R. (2001) · Cited by 2,510
Pisters, P. W., Leung, D. H., Woodruff, J., Shi, W., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1679 · Cited by 1,220
The evolving classification of soft tissue tumours: an update based on the new WHO classification
Fletcher, C. D. M. (2006) · Histopathology · doi:10.1111/j.1365-2559.2005.02284.x · Cited by 913
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*
MANKIN, H. J., MANKIN, C. J., & SIMON, M. A. (1996) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199605000-00004 · Cited by 773
Toro, J. R., Travis, L. B., Wu, H. J., Zhu, K., Fletcher, C. D. M., & Devesa, S. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22239 · Cited by 680
Postoperative Nomogram for 12-Year Sarcoma-Specific Death
Kattan, M. W., Leung, D. H. Y., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.791 · Cited by 609
Van Glabbeke, M., van Oosterom, A. T., Oosterhuis, J. W., Mouridsen, H., Crowther, D., Somers, R., Verweij, J., Santoro, A., Buesa, J., & Tursz, T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.150 · Cited by 608
Rhabdomyosarcoma in adults: A retrospective analysis of 171 patients treated at a single institution
Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., et al. (2003) · Cancer · doi:10.1002/cncr.11550 · Cited by 403
Self-citationCarli, M., Ferrari, A., Mattke, A., Zanetti, I., Casanova, M., Bisogno, G., Cecchetto, G., Alaggio, R., De Sio, L., Koscielniak, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4886 · Cited by 371
Self-citationCutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases
Rouhani, P., Fletcher, C. D. M., Devesa, S. S., & Toro, J. R. (2008) · Cancer · doi:10.1002/cncr.23571 · Cited by 342
Joshi, D., Anderson, J. R., Paidas, C., Breneman, J., Parham, D. M., & Crist, W. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.10441 · Cited by 232
Mariani, L., Miceli, R., Kattan, M. W., Brennan, M. F., Colecchia, M., Fiore, M., Casali, P. G., & Gronchi, A. (2005) · Cancer · doi:10.1002/cncr.20778 · Cited by 211
Presant, C. A., Russell, W. O., Alexander, R. W., & Fu, Y. S. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.11.1658 · Cited by 162
Ferrari, A., Casanova, M., Collini, P., Meazza, C., Luksch, R., Massimino, M., Cefalo, G., Terenziani, M., Spreafico, F., Catania, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.053 · Cited by 138
Self-citationThe value of expert second opinion in diagnosis of soft tissue sarcomas
Lehnhardt, M., Daigeler, A., Hauser, J., Puls, A., Soimaru, C., Kuhnen, C., & Steinau, H. U. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20897 · Cited by 98
Clinical relevance of molecular genetics to paediatric sarcomas
Slater, O., & SHIPLEY, J. M. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.040113 · Cited by 57
Current chemotherapeutic strategies for rhabdomyosarcoma
Ferrari, A., & Casanova, M. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.2.283 · Cited by 38
Self-citation
Cited by
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 683
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Janssen, F. W., Lak, N. S. M., Janda, C. Y., Kester, L. A., Meister, M. T., Merks, J. H. M., van den Heuvel-Eibrink, M. M., van Noesel, M. M., Zsiros, J., Tytgat, G. A. M., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00657-z · Cited by 32
Metadata
- Authors
- Ferrari, A., Sultan, I., Huang, T. T., Rodriguez‐Galindo, C., Shehadeh, A., Meazza, C., Ness, K. K., Casanova, M., & Spunt, S. L.
- Venue
- Pediatric Blood & Cancer
- Publisher
- Wiley
- Published
- 2011-07-25
- Volume
- 57
- Issue
- 6
- Pages
- 943-949
- ISSN
- 1545-5009 (ISSN-L)
- 1545-5017
- OpenAlex
- W2158251086
- Cited by
- 376
- References
- 18
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.